NVCT - Nuvectis Pharma, Inc.

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts3333
Avg. Estimate-0.29-0.3-1.19-1.26
Low estimate-0.41-0.45-1.65-1.81
High estimate-0.2-0.2-0.9-0.94
Year ago EPS-0.32-0.28-1.51-1.19
Revenue estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts3333
Avg. EstimateN/AN/AN/AN/A
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/AN/A
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history30/03/202229/06/202229/09/202230/03/2023
Est. EPS-0.23-0.23-0.27-0.44
Actual EPS-0.32-0.28-0.42-0.27
Difference-0.09-0.05-0.150.17
Surprise %-39.10%-21.70%-55.60%38.60%
EPS trendCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Current estimate-0.29-0.3-1.19-1.26
7 days ago-0.29-0.3-1.19-1.26
30 days ago-0.44-0.43-1.75-1.96
60 days ago-0.44-0.43-1.75-1.96
90 days ago-0.44-0.43-1.75-1.96
EPS revisionsCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days2222
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesNVCTIndustrySector(s)S&P 500
Current qtr.9.40%N/AN/AN/A
Next qtr.-7.10%N/AN/AN/A
Current year21.20%N/AN/AN/A
Next year-5.90%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A